Skip to main content
Erschienen in: Supportive Care in Cancer 5/2021

15.09.2020 | COVID-19 | Original Article Zur Zeit gratis

Palliative care provision at a tertiary cancer center during a global pandemic

verfasst von: Breffni Hannon, Ernie Mak, Ahmed Al Awamer, Subrata Banerjee, Christopher Blake, Ebru Kaya, Jenny Lau, Warren Lewin, Brenda O’Connor, Alexandra Saltman, Camilla Zimmermann

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

COVID-19 was first reported in Wuhan, China, in December 2019; it rapidly spread around the world and was declared a global pandemic by the World Health Organization in March 2020. The palliative care program at the Princess Margaret Cancer Centre, Toronto, Canada, provides comprehensive care to patients with advanced cancer and their families, through services including an acute palliative care unit, an inpatient consultation service, and an ambulatory palliative care clinic. In the face of a global pandemic, palliative care teams are uniquely placed to support patients with cancer who also have COVID-19. This may include managing severe symptoms such as dyspnea and agitation, as well as guiding advance care planning and goals of care conversations. In tandem, there is a need for palliative care teams to continue to provide care to patients with advanced cancer who are COVID-negative but who are at higher risk of infection and adverse outcomes related to COVID-19. This paper highlights the unique challenges faced by a palliative care team in terms of scaling up services in response to a global pandemic while simultaneously providing ongoing support to their patients with advanced cancer at a tertiary cancer center.
Literatur
1.
Zurück zum Zitat Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei CL, Hui DSC, du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720CrossRef Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei CL, Hui DSC, du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720CrossRef
4.
Zurück zum Zitat Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337CrossRef Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J (2020) Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 21(3):335–337CrossRef
5.
Zurück zum Zitat Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL et al (2020) Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Cancer Netw 18(4):1–4 Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL et al (2020) Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Cancer Netw 18(4):1–4
6.
10.
Zurück zum Zitat Arya A, Buchman S, Gagnon B, Downar J (2020) Pandemic palliative care: beyond ventilators and saving lives. Can Med Assoc J 192(15):cmaj.200465CrossRef Arya A, Buchman S, Gagnon B, Downar J (2020) Pandemic palliative care: beyond ventilators and saving lives. Can Med Assoc J 192(15):cmaj.200465CrossRef
11.
Zurück zum Zitat Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721–1730CrossRef Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721–1730CrossRef
12.
Zurück zum Zitat Hannon B, Swami N, Pope A, Rodin G, Dougherty E, Mak E, Banerjee S, Bryson J, Ridley J, Zimmermann C (2015) The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer. Support Care Cancer 23(4):1073–1080CrossRef Hannon B, Swami N, Pope A, Rodin G, Dougherty E, Mak E, Banerjee S, Bryson J, Ridley J, Zimmermann C (2015) The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer. Support Care Cancer 23(4):1073–1080CrossRef
13.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5(6):649–655CrossRef Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5(6):649–655CrossRef
14.
Zurück zum Zitat Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, Atkins M, Fassbender K, Downing GM, Baracos V (2010) Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 28(28):4376–4383CrossRef Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, Atkins M, Fassbender K, Downing GM, Baracos V (2010) Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 28(28):4376–4383CrossRef
19.
Zurück zum Zitat Zimmermann C, Seccareccia D, Clarke A, Warr D, Rodin G (2006) Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital. Support Care Cancer 14(10):982–987CrossRef Zimmermann C, Seccareccia D, Clarke A, Warr D, Rodin G (2006) Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital. Support Care Cancer 14(10):982–987CrossRef
20.
Zurück zum Zitat Bryson J, Coe G, Swami N, Murphy-Kane P, Seccareccia D, le LW, Rodin G, Zimmermann C (2010) Administrative outcomes five years after opening an acute palliative care unit at a comprehensive cancer centre. J Palliat Med 13(5):559–565CrossRef Bryson J, Coe G, Swami N, Murphy-Kane P, Seccareccia D, le LW, Rodin G, Zimmermann C (2010) Administrative outcomes five years after opening an acute palliative care unit at a comprehensive cancer centre. J Palliat Med 13(5):559–565CrossRef
21.
Zurück zum Zitat Costantini M, Sleeman KE, Peruselli C, Higginson IJ (2020). Response and role of palliative care during the COVID-19 pandemic: a national telephone survey of hospices in Italy. medRxiv.2020.03.18.20038448 Costantini M, Sleeman KE, Peruselli C, Higginson IJ (2020). Response and role of palliative care during the COVID-19 pandemic: a national telephone survey of hospices in Italy. medRxiv.2020.03.18.20038448
22.
Zurück zum Zitat Cheng HWB, Li CW, Chan KY, Sham MK (2014) The first confirmed case of human avian influenza A(H7N9) in Hong Kong and the suspension of volunteer services: Impact on palliative care. J Pain Symptom Manage 47(6):2013–2015CrossRef Cheng HWB, Li CW, Chan KY, Sham MK (2014) The first confirmed case of human avian influenza A(H7N9) in Hong Kong and the suspension of volunteer services: Impact on palliative care. J Pain Symptom Manage 47(6):2013–2015CrossRef
Metadaten
Titel
Palliative care provision at a tertiary cancer center during a global pandemic
verfasst von
Breffni Hannon
Ernie Mak
Ahmed Al Awamer
Subrata Banerjee
Christopher Blake
Ebru Kaya
Jenny Lau
Warren Lewin
Brenda O’Connor
Alexandra Saltman
Camilla Zimmermann
Publikationsdatum
15.09.2020
Verlag
Springer Berlin Heidelberg
Schlagwort
COVID-19
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05767-5

Weitere Artikel der Ausgabe 5/2021

Supportive Care in Cancer 5/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.